{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:32:14Z","timestamp":1792985534973,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008653","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000}}],"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM122845"],"award-info":[{"award-number":["R01GM122845"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AD057555"],"award-info":[{"award-number":["R01AD057555"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AD057555"],"award-info":[{"award-number":["R01AD057555"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CUNY High Performance Computing Center"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Drug combinations have demonstrated great potential in cancer treatments. They alleviate drug resistance and improve therapeutic efficacy. The fast-growing number of anti-cancer drugs has caused the experimental investigation of all drug combinations to become costly and time-consuming. Computational techniques can improve the efficiency of drug combination screening. Despite recent advances in applying machine learning to synergistic drug combination prediction, several challenges remain. First, the performance of existing methods is suboptimal. There is still much space for improvement. Second, biological knowledge has not been fully incorporated into the model. Finally, many models are lack interpretability, limiting their clinical applications. To address these challenges, we have developed a knowledge-enabled and self-attention transformer boosted deep learning model, TranSynergy, which improves the performance and interpretability of synergistic drug combination prediction. TranSynergy is designed so that the cellular effect of drug actions can be explicitly modeled through cell-line gene dependency, gene-gene interaction, and genome-wide drug-target interaction. A novel Shapley Additive Gene Set Enrichment Analysis (SA-GSEA) method has been developed to deconvolute genes that contribute to the synergistic drug combination and improve model interpretability. Extensive benchmark studies demonstrate that TranSynergy outperforms the state-of-the-art method, suggesting the potential of mechanism-driven machine learning. Novel pathways that are associated with the synergistic combinations are revealed and supported by experimental evidences. They may provide new insights into identifying biomarkers for precision medicine and discovering new anti-cancer therapies. Several new synergistic drug combinations have been predicted with high confidence for ovarian cancer which has few treatment options. The code is available at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/github.com\/qiaoliuhub\/drug_combination\" xlink:type=\"simple\">https:\/\/github.com\/qiaoliuhub\/drug_combination<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1008653","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T16:59:11Z","timestamp":1613149151000},"page":"e1008653","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":198,"title":["TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9966-7101","authenticated-orcid":true,"given":"Qiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-2111","authenticated-orcid":true,"given":"Lei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"issue":"3","key":"pcbi.1008653.ref001","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The Different Mechanisms of Cancer Drug Resistance","volume":"7","author":"B Mansoori","year":"2017","journal-title":"A Brief Review. Adv Pharm Bull"},{"issue":"3","key":"pcbi.1008653.ref002","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"G Housman","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"4","key":"pcbi.1008653.ref003","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","article-title":"The challenge of drug resistance in cancer treatment: a current overview","volume":"35","author":"M Nikolaou","year":"2018","journal-title":"Clin Exp Metastasis."},{"issue":"23","key":"pcbi.1008653.ref004","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"R Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"pcbi.1008653.ref005","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.ejmech.2017.10.021","article-title":"Dual or multi-targeting inhibitors: The next generation anticancer agents","volume":"143","author":"NM Raghavendra","year":"2018","journal-title":"Eur J Med Chem."},{"issue":"1","key":"pcbi.1008653.ref006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"RR Ramsay","year":"2018","journal-title":"Clin Transl Med"},{"issue":"9","key":"pcbi.1008653.ref007","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nchembio817","article-title":"Systems biology and combination therapy in the quest for clinical efficacy","volume":"2","author":"JB Fitzgerald","year":"2006","journal-title":"Nat Chem Biol."},{"issue":"7","key":"pcbi.1008653.ref008","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"J Lehar","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"4","key":"pcbi.1008653.ref009","first-page":"12","article-title":"Attacking AIDS with a \u2019cocktail\u2019 therapy?","volume":"33","author":"J. Henkel","year":"1999","journal-title":"FDA Consum."},{"key":"pcbi.1008653.ref010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1054-3589(07)56002-3","article-title":"Current clinical treatments of AIDS","volume":"56","author":"EM Murphy","year":"2008","journal-title":"Adv Pharmacol."},{"issue":"7","key":"pcbi.1008653.ref011","doi-asserted-by":"crossref","first-page":"e1004975","DOI":"10.1371\/journal.pcbi.1004975","article-title":"NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning","volume":"12","author":"X Chen","year":"2016","journal-title":"PLoS Comput Biol."},{"issue":"3","key":"pcbi.1008653.ref012","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.seminhematol.2009.03.003","article-title":"Recent advances in antifungal prevention and treatment","volume":"46","author":"AH Groll","year":"2009","journal-title":"Semin Hematol"},{"issue":"3","key":"pcbi.1008653.ref013","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"PD Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"pcbi.1008653.ref014","first-page":"2999","article-title":"New anticancer agents: recent developments in tumor therapy","volume":"32","author":"R Ali","year":"2012","journal-title":"Anticancer Res."},{"key":"pcbi.1008653.ref015","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","article-title":"Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium","volume":"9","author":"L Falzone","year":"2018","journal-title":"Front Pharmacol"},{"key":"pcbi.1008653.ref016","doi-asserted-by":"crossref","first-page":"13891","DOI":"10.1038\/srep13891","article-title":"High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations","volume":"5","author":"BT Mott","year":"2015","journal-title":"Sci Rep"},{"issue":"6","key":"pcbi.1008653.ref017","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.jcim.9b00266","article-title":"Deep Learning in Chemistry","volume":"59","author":"AC Mater","year":"2019","journal-title":"J Chem Inf Model"},{"issue":"7","key":"pcbi.1008653.ref018","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2217\/pgs-2018-0008","article-title":"Deep learning in pharmacogenomics: from gene regulation to patient stratification","volume":"19","author":"AA Kalinin","year":"2018","journal-title":"Pharmacogenomics"},{"issue":"2","key":"pcbi.1008653.ref019","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drudis.2015.09.003","article-title":"Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives","volume":"21","author":"KC Bulusu","year":"2016","journal-title":"Drug Discov Today"},{"issue":"6","key":"pcbi.1008653.ref020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies","volume":"15","author":"J O\u2019Neil","year":"2016","journal-title":"Mol Cancer Ther."},{"issue":"18","key":"pcbi.1008653.ref021","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1158\/0008-5472.CAN-18-0740","article-title":"Network Propagation Predicts Drug Synergy in Cancers","volume":"78","author":"H Li","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"pcbi.1008653.ref022","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-019-09799-2","article-title":"Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen","volume":"10","author":"MP Menden","year":"2019","journal-title":"Nat Commun"},{"issue":"13","key":"pcbi.1008653.ref023","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","article-title":"The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity","volume":"77","author":"SL Holbeck","year":"2017","journal-title":"Cancer Res"},{"issue":"9","key":"pcbi.1008653.ref024","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"DeepSynergy: predicting anti-cancer drug synergy with Deep Learning","volume":"34","author":"K Preuer","year":"2018","journal-title":"Bioinformatics"},{"issue":"3","key":"pcbi.1008653.ref025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/bmjqs-2018-008370","article-title":"Artificial intelligence, bias and clinical safety","volume":"28","author":"R Challen","year":"2019","journal-title":"BMJ Qual Saf."},{"issue":"5","key":"pcbi.1008653.ref026","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1109\/72.623216","article-title":"Are artificial neural networks black boxes?","volume":"8","author":"JM Benitez","year":"1997","journal-title":"IEEE Trans Neural Netw."},{"issue":"7623","key":"pcbi.1008653.ref027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/538020a","article-title":"Can we open the black box of AI?","volume":"538","author":"D. Castelvecchi","year":"2016","journal-title":"Nature"},{"issue":"1","key":"pcbi.1008653.ref028","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"F Cheng","year":"2019","journal-title":"Nat Commun."},{"key":"pcbi.1008653.ref029","author":"A Vaswani","year":"2017","journal-title":"Attention Is All You Need"},{"key":"pcbi.1008653.ref030","author":"M-T Luong","year":"2015","journal-title":"Effective Approaches to Attention-based Neural Machine Translation"},{"key":"pcbi.1008653.ref031","author":"D Bahdanau","year":"2014","journal-title":"Neural Machine Translation by Jointly Learning to Align and Translate"},{"issue":"10","key":"pcbi.1008653.ref032","doi-asserted-by":"crossref","first-page":"e1007480","DOI":"10.1371\/journal.pcbi.1007480","article-title":"Prediction of off-target specificity and cell-specific fitness of CRISPR-Cas System using attention boosted deep learning and network-based gene feature","volume":"15","author":"Q Liu","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1008653.ref033","author":"S Lundberg","year":"2017","journal-title":"A Unified Approach to Interpreting Model Predictions"},{"issue":"10","key":"pcbi.1008653.ref034","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.bbadis.2014.06.015","article-title":"Next generation sequencing technology: Advances and applications","volume":"1842","author":"HP Buermans","year":"2014","journal-title":"Biochim Biophys Acta."},{"issue":"Suppl 24","key":"pcbi.1008653.ref035","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s12859-019-3241-3","article-title":"Biological representation of chemicals using latent target interaction profile","volume":"20","author":"M Ayed","year":"2019","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"pcbi.1008653.ref036","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"DS Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pcbi.1008653.ref037","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"A Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1008653.ref038","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1038\/s41467-018-06916-5","article-title":"Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration","volume":"9","author":"JM McFarland","year":"2018","journal-title":"Nat Commun"},{"issue":"Suppl_10","key":"pcbi.1008653.ref039","doi-asserted-by":"crossref","first-page":"x12","DOI":"10.1093\/annonc\/mdz381","article-title":"Efficacy of PI3K inhibitors in advanced breast cancer","volume":"30","author":"B Verret","year":"2019","journal-title":"Ann Oncol"},{"issue":"8","key":"pcbi.1008653.ref040","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ctrv.2013.03.009","article-title":"Targeting the PI3K\/AKT\/mTOR and Raf\/MEK\/ERK pathways in the treatment of breast cancer","volume":"39","author":"KS Saini","year":"2013","journal-title":"Cancer Treat Rev."},{"issue":"5","key":"pcbi.1008653.ref041","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrc2607","article-title":"Targeting DNA topoisomerase II in cancer chemotherapy","volume":"9","author":"JL Nitiss","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"pcbi.1008653.ref042","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/jcmm.12162","article-title":"Co-targeting the PI3K\/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms","volume":"17","author":"N Bartalucci","year":"2013","journal-title":"J Cell Mol Med"},{"issue":"4","key":"pcbi.1008653.ref043","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00277-008-0603-8","article-title":"BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia","volume":"88","author":"J Bhattacharyya","year":"2009","journal-title":"Ann Hematol."},{"issue":"10","key":"pcbi.1008653.ref044","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/MCB.00981-10","article-title":"BMI1 is recruited to DNA breaks and contributes to DNA damage-induced H2A ubiquitination and repair","volume":"31","author":"V Ginjala","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"7","key":"pcbi.1008653.ref045","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Y. Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"pcbi.1008653.ref046","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.dnarep.2019.03.007","article-title":"SWI\/SNF: Complex complexes in genome stability and cancer","volume":"77","author":"C Ribeiro-Silva","year":"2019","journal-title":"DNA Repair (Amst)"},{"issue":"8","key":"pcbi.1008653.ref047","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/bjc.2011.382","article-title":"The role of PARP in DNA repair and its therapeutic exploitation","volume":"105","author":"M Javle","year":"2011","journal-title":"Br J Cancer"},{"key":"pcbi.1008653.ref048","article-title":"A deep learning framework for elucidating whole-genome chemical interaction space","volume":"2020","author":"T Cai","journal-title":"bioRxiv."},{"issue":"1","key":"pcbi.1008653.ref049","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2294","article-title":"The properties of high-dimensional data spaces: implications for exploring gene and protein expression data","volume":"8","author":"R Clarke","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"pcbi.1008653.ref050","first-page":"219","article-title":"A Deep Learning Approach for Cancer Detection and Relevant Gene Identification","volume":"22","author":"P Danaee","year":"2017","journal-title":"Pac Symp Biocomput."},{"key":"pcbi.1008653.ref051","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"T-C Chou","year":"1983","journal-title":"Trends in Pharmacological Sciences"},{"key":"pcbi.1008653.ref052","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul."},{"issue":"2","key":"pcbi.1008653.ref053","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"TC Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"pcbi.1008653.ref054","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"THE TOXICITY OF POISONS APPLIED JOINTLY1","volume":"26","author":"CI Bliss","year":"1939","journal-title":"Annals of Applied Biology"},{"issue":"2","key":"pcbi.1008653.ref055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","article-title":"A method for testing for synergy with any number of agents","volume":"137","author":"MC Berenbaum","year":"1978","journal-title":"J Infect Dis"},{"issue":"2","key":"pcbi.1008653.ref056","first-page":"331","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"WR Greco","year":"1995","journal-title":"Pharmacol Rev."},{"issue":"5","key":"pcbi.1008653.ref057","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01952257","article-title":"\u00dcber Kombinationswirkungen","volume":"114","author":"S Loewe","year":"1926","journal-title":"Naunyn-Schmiedebergs Archiv f\u00fcr experimentelle Pathologie und Pharmakologie"},{"issue":"6","key":"pcbi.1008653.ref058","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"S. Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"issue":"141","key":"pcbi.1008653.ref059","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0387","article-title":"Opportunities and obstacles for deep learning in biology and medicine","volume":"15","author":"T Ching","year":"2018","journal-title":"J R Soc Interface"},{"key":"pcbi.1008653.ref060","doi-asserted-by":"crossref","unstructured":"Heaton J, McElwee S, Fraley J, Cannady J, editors. Early stabilizing feature importance for TensorFlow deep neural networks. 2017 International Joint Conference on Neural Networks (IJCNN); 2017 14\u201319 May 2017.","DOI":"10.1109\/IJCNN.2017.7966442"},{"issue":"10","key":"pcbi.1008653.ref061","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nmeth.3547","article-title":"Predicting effects of noncoding variants with deep learning-based sequence model","volume":"12","author":"J Zhou","year":"2015","journal-title":"Nat Methods"},{"key":"pcbi.1008653.ref062","author":"JT Springenberg","year":"2014","journal-title":"Striving for Simplicity: The All Convolutional Net"},{"key":"pcbi.1008653.ref063","author":"S Jain","year":"2019","journal-title":"Attention is not Explanation"},{"issue":"2","key":"pcbi.1008653.ref064","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/0008-5472.CAN-16-0097","article-title":"Quantification of Pathway Cross-talk Reveals Novel Synergistic Drug Combinations for Breast Cancer","volume":"77","author":"S Jaeger","year":"2017","journal-title":"Cancer Res"},{"key":"pcbi.1008653.ref065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fphar.2018.00535","article-title":"Searching Synergistic Dose Combinations for Anticancer Drugs","volume":"9","author":"Z Yin","year":"2018","journal-title":"Front Pharmacol."},{"key":"pcbi.1008653.ref066","doi-asserted-by":"crossref","unstructured":"Tong H, Faloutsos C, Pan J, editors. Fast Random Walk with Restart and Its Applications. Sixth International Conference on Data Mining (ICDM\u201906); 2006 18\u201322 Dec. 2006.","DOI":"10.1109\/ICDM.2006.70"},{"issue":"D1","key":"pcbi.1008653.ref067","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"D Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1008653.ref068","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw100","article-title":"The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins","volume":"2016","author":"AD Rouillard","year":"2016","journal-title":"Database (Oxford)"},{"issue":"7391","key":"pcbi.1008653.ref069","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"key":"pcbi.1008653.ref070","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"pcbi.1008653.ref071","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A Landscape of Pharmacogenomic Interactions in Cancer","volume":"166","author":"F Iorio","year":"2016","journal-title":"Cell"},{"key":"pcbi.1008653.ref072","first-page":"720243","article-title":"Extracting Biological Insights from the Project Achilles Genome-Scale CRISPR Screens in Cancer Cell Lines","author":"JM Dempster","year":"2019","journal-title":"bioRxiv"},{"key":"pcbi.1008653.ref073","unstructured":"Broad D. DepMap 20Q1 Public2020."},{"issue":"12","key":"pcbi.1008653.ref074","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"RM Meyers","year":"2017","journal-title":"Nat Genet"},{"key":"pcbi.1008653.ref075","unstructured":"Broad D. Project SCORE processed with CERES2019."},{"issue":"7753","key":"pcbi.1008653.ref076","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","volume":"568","author":"FM Behan","year":"2019","journal-title":"Nature."},{"issue":"3","key":"pcbi.1008653.ref077","first-page":"67","volume":"45","author":"S van Buuren","year":"2011","journal-title":"mice: Multivariate Imputation by Chained Equations in R. 2011"},{"issue":"43","key":"pcbi.1008653.ref078","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pcbi.1008653.ref079","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"A Liberzon","year":"2011","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008653","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T22:17:16Z","timestamp":1671229036000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008653"}},"subtitle":[],"editor":[{"given":"Avner","family":"Schlessinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008653","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.08.193904","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}